Sidney Harman died last night of complications from acute myeloid leukemia at the young age of almost 93.

FORBES: Audio Pioneer and Newsweek Owner Sidney Harman Dies At 92

In about one-third of patients, the disease progresses to become acute myeloid leukemia.

FORBES: Celgene Aims For Fast FDA Approval

However, analyzing the data from another study indicated that elesclomol was highly active against cells from acute myeloid leukemia (AML).

NEWYORKER: The Treatment

This is an unusual activty as acute myeloid leukemia is characterized by progressively shorter remission periods regardless of the drug regimen, says the analyst.

FORBES: Intrepid Investors Eye Use Of Pig Whipworm Eggs To Quell Crohn's Disease and MS

Novartis is in final trials of a drug that may help the one-third of acute myeloid leukemia cases with a gene mutation that turns on cell-growth signals.

FORBES: Magazine Article

The first of its two clinical-stage product candidates is a potential treatment for acute myeloid leukemia, a cancer that receives about 14, 000 new diagnoses in the U.S. annually.

WSJ: Stemline Therapeutics Jumps in Debut

Another compound, in middle-stage testing, targets acute myeloid leukemia.

FORBES: Big Bucks

Like Ellen, Zoe had acute myeloid leukemia.

FORBES: Two Girls Two Countries One Cancer